Related Experiment Video
Updated: Jun 17, 2026
11:44
Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
Innate immune dysfunction in acute and chronic liver disease
Bettina Leber1, Ursula Mayrhauser, Michael Rybczynski
1Division of Surgery, Medical University of Graz, Graz, Austria.
Wiener Klinische Wochenschrift
|January 5, 2010
Summary
Innate immune dysfunction in liver cirrhosis and acute liver failure contributes to infections and organ failure. Therapeutic strategies targeting these defects offer potential for improved patient outcomes.
Area of Science:
- Hepatology
- Immunology
- Critical Care Medicine
Background:
- Liver cirrhosis and acute liver failure (ALF) are associated with significant morbidity and mortality, often driven by infections.
- Infections are a major complication, frequently leading to decompensation, organ failure, and death in patients with chronic liver disease.
- Understanding innate immune system defects is crucial for managing these liver conditions.
Purpose of the Study:
- To review innate immune function in cirrhosis, acute-on-chronic liver failure, and ALF.
- To discuss the pathophysiological mechanisms underlying immune defects in these conditions.
- To present current and experimental therapeutic strategies.
Main Methods:
- Review of literature on innate immunity in liver disease.
- Discussion of cellular defects (Kupffer cells, neutrophils, monocytes) and their implications.
- Analysis of pathomechanisms including gut permeability, portal hypertension, and molecular pathways (endotoxin, TLRs).
Main Results:
- Defects in Kupffer cells, neutrophils, and monocytes impair immune responses in liver disease.
- Gut permeability, portal hypertension, and molecular factors like endotoxin and toll-like receptors (TLRs) play significant roles.
- Various therapeutic strategies, including antibiotics, probiotics, and novel approaches targeting TLRs, are being explored.
Conclusions:
- Innate immune dysfunction is a critical factor in the progression and complications of liver cirrhosis and ALF.
- Targeting specific immune defects and pathomechanisms holds promise for therapeutic interventions.
- Further research into immune modulation and supportive therapies is essential for improving patient survival and quality of life.
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...